Timothy J. Guzi

2.7k citations

31 papers · 1.4k indexed · h-index 16

Molecular Biology top 10%
Oncology top 5%
Organic Chemistry top 10%
Pulmonary and Respiratory Medicine top 10%
Cell Biology top 10%

Co-authors: David Parry Michael P. Dwyer Wolfgang Seghezzi Kamil Paruch Derek Wiswell Thierry Fischmann Nicole R. Davis Fergus Shanahan
Topics: Cancer-related Molecular Pathways (8 papers)DNA Repair Mechanisms (7 papers)Fibroblast Growth Factor Research (4 papers)
Cited by: Oncology Molecular Biology Cell Biology
Journals: Blood Cancer Research Journal of Hepatology
Partner nations: United States Ireland South Korea

In The Last Decade

Timothy J. Guzi

31 papers receiving 1.3k citations

Peers

Countries citing papers authored by Timothy J. Guzi

Since Specialization

Citations

This map shows the geographic impact of Timothy J. Guzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy J. Guzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy J. Guzi more than expected).

Fields of papers citing papers by Timothy J. Guzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy J. Guzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy J. Guzi. The network helps show where Timothy J. Guzi may publish in the future.

Co-authorship network of co-authors of Timothy J. Guzi

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy J. Guzi. A scholar is included among the top collaborators of Timothy J. Guzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy J. Guzi. Timothy J. Guzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human polymerase θ helicase positions DNA microhomologies for double-strand break repair 2025 ·Nature Structural & Molecular Biology ·(unknown),(unknown),(unknown),Timothy J. Guzi,Gabriel C. Lander	3
2	Abstract 4205: Direct measurement of TA repeat expansions significantly outperforms MSI-H status as a predictor of sensitivity to the novel WRN inhibitor MOMA-341 2025 ·Cancer Research ·Anthony Tubbs,Javad Golji,Meredeth A. McGowan,(unknown),(unknown),(unknown),(unknown),(unknown),Momar Toure,(unknown),Haoxuan Wang,Cen Gao,Timothy J. Guzi,Peter S. Hammerman,(unknown),(unknown)	2
3	A convergent preparation of the CHK1 inhibitor MK-8776 (SCH 900776) 2016 ·Tetrahedron Letters ·Marc Labroli,Michael P. Dwyer,(unknown),Kerry Keertikar,Randall R. Rossman,Timothy J. Guzi	4
4	Abstract 2641: The development of potent, selective RET inhibitors that target both wild-type RET and prospectively identified resistance mutations to multi-kinase inhibitors 2016 ·Cancer Research ·Rami Rahal,Erica N Evans,Wei Hu,Michelle Maynard,Paul Fleming,Lucian DiPietro,Joseph L. Kim,Michael P. Sheets,(unknown),Kevin Wilson,Nicolas Stransky,Jason D. Brubaker,Timothy J. Guzi,Nancy E. Kohl,Christoph Lengauer	10
5	First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway 2015 ·Cancer Discovery ·Margit Hagel,Chandra Miduturu,Michael P. Sheets,Nooreen Rubin,Weifan Weng,Nicolas Stransky,Neil Bifulco,Joseph L. Kim,Brian L. Hodous,Natasja Brooijmans,Adam Shutes,Christopher Winter,Christoph Lengauer,Nancy E. Kohl,Timothy J. Guzi	247
6	The identification of novel 5′-amino gemcitabine analogs as potent RRM1 inhibitors 2014 ·Bioorganic & Medicinal Chemistry ·Marc Labroli,Michael P. Dwyer,Ruichao Shen,Janeta Popovici-Müller,(unknown),Daniel F. Wyss,Mark A. McCoy,Dianah Barrett,Nicole R. Davis,Wolfgang Seghezzi,Fergus Shanahan,Lorena Taricani,Maribel Beaumont,(unknown),David Parry,Timothy J. Guzi	10
7	Discovery of pyrazolo[1,5-a]pyrimidine-based Pim inhibitors: A template-based approach 2013 ·Bioorganic & Medicinal Chemistry Letters ·Michael P. Dwyer,(unknown),Kamil Paruch,Carmen Álvarez,Marc Labroli,(unknown),Thierry Fischmann,Rosemary Mayer‐Ezell,Richard Bond,Yan Wang,(unknown),Timothy J. Guzi	35
8	Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening 2011 ·Molecular Cancer Therapeutics ·Timothy J. Guzi,Kamil Paruch,Michael P. Dwyer,Marc Labroli,Fergus Shanahan,Nicole R. Davis,Lorena Taricani,Derek Wiswell,Wolfgang Seghezzi,(unknown),(unknown),Wei Wang,Danling Gu,Yunsheng Hsieh,Suining Lee,Ming Liu,David Parry	135
9	Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor 2010 ·Molecular Cancer Therapeutics ·David Parry,Timothy J. Guzi,Fergus Shanahan,Nicole R. Davis,Deepa Prabhavalkar,Derek Wiswell,Wolfgang Seghezzi,Kamil Paruch,Michael P. Dwyer,Ronald J. Doll,Amin A. Nomeir,William T. Windsor,Thierry Fischmann,Yaolin Wang,Martin Oft,Taiying Chen,Paul T. Kirschmeier,Emma Lees	434
10	Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach—Part 1 2010 ·Bioorganic & Medicinal Chemistry Letters ·Michael P. Dwyer,Kamil Paruch,Marc Labroli,Carmen Álvarez,Kerry Keertikar,(unknown),Randall R. Rossman,Thierry Fischmann,José S. Duca,Vincent Madison,David Parry,Nicole R. Davis,Wolfgang Seghezzi,Derek Wiswell,Timothy J. Guzi	55
11	Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach—Part 2 2010 ·Bioorganic & Medicinal Chemistry Letters ·Marc Labroli,Kamil Paruch,Michael P. Dwyer,Carmen Álvarez,(unknown),(unknown),Randall R. Rossman,José S. Duca,Thierry Fischmann,Vincent Madison,David Parry,Nicole R. Davis,Wolfgang Seghezzi,Derek Wiswell,Timothy J. Guzi	62
12	Design, synthesis and SAR of thienopyridines as potent CHK1 inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Lianyun Zhao,Yingxin Zhang,Chaoyang Dai,Timothy J. Guzi,Derek Wiswell,Wolfgang Seghezzi,David Parry,Thierry Fischmann,M. Arshad Siddiqui	34
13	Phenotypic enhancement of thymidylate synthetase pathway inhibitors following ablation of Neil1 DNA glycosylase/lyase 2010 ·Cell Cycle ·Lorena Taricani,Fergus Shanahan,(unknown),Timothy J. Guzi,David Parry	20
14	In vitro and in vivo characterization of SCH727965 a novel potent cyclin dependent kinase inhibitor 2007 ·Cancer Research ·David Parry,Timothy J. Guzi,Wolfgang Seghezzi,Kamil Paruch,Ronald J. Doll,Amin A. Nomeir,Yaolin Wang,Martin Oft,Paul T. Kirschmeier,Taiying Chen,Emma Lees	3
15	Structure‐guided discovery of cyclin‐dependent kinase inhibitors 2007 ·Biopolymers ·Thierry Fischmann,Alan Hruza,José S. Duca,Lata Ramanathan,Todd Mayhood,William T. Windsor,Hung V. Le,Timothy J. Guzi,Michael P. Dwyer,Kamil Paruch,Ronald J. Doll,Emma Lees,David Parry,Wolfgang Seghezzi,Vincent Madison	46
16	Versatile templates for the development of novel kinase inhibitors: Discovery of novel CDK inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Michael P. Dwyer,Kamil Paruch,Carmen Álvarez,Ronald J. Doll,Kerry Keertikar,José S. Duca,Thierry Fischmann,Alan Hruza,Vincent Madison,Emma Lees,David Parry,Wolfgang Seghezzi,(unknown),Fergus Shanahan,Derek Wiswell,Timothy J. Guzi	29
17	CYC-202 Cyclacel. 2004 ·PubMed ·Timothy J. Guzi	21
18	Synthesis of substituted 1H-imidazol-1-ylmethylpiperidines. Facile separation of 1,4- and 1,5-disubstituted imidazoles 2002 ·Tetrahedron Letters ·(unknown),(unknown),(unknown),(unknown),(unknown),Jianping Chao,(unknown),Timothy J. Guzi	2
19	Analogues of 1-(3,10-Dibromo-8-chloro-6,11-dihydro-5 H -benzo[5,6]-cyclohepta[1,2- b ]pyridin-11-yl)piperidine as inhibitors of farnesyl protein transferase 1999 ·Bioorganic & Medicinal Chemistry ·Adriano Afonso,Jay Weinstein,Joseph Kelly,Ronald Wolin,Stuart B. Rosenblum,(unknown),Timothy J. Guzi,Linda James,Donna Carr,Robert Patton,W. Robert Bishop,(unknown),(unknown),Larry Heimark,(unknown),Amin A. Nomeir	8
20	A novel synthesis of piperidin-3-ones via an intramolecular Amadori-type reaction 1996 ·Tetrahedron Letters ·Timothy J. Guzi,Timothy L. Macdonald	6

About Timothy J. Guzi

Timothy J. Guzi is a scholar working on Toxicology, Oncology and Molecular Biology, having authored 31 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), DNA Repair Mechanisms (7 papers) and Fibroblast Growth Factor Research (4 papers). The work is most often cited by research in Oncology (538 citations), Molecular Biology (792 citations) and Cell Biology (160 citations). Timothy J. Guzi has collaborated with scholars based in United States, Ireland and South Korea. Frequent co-authors include David Parry, Michael P. Dwyer, Wolfgang Seghezzi, Kamil Paruch, Derek Wiswell, Thierry Fischmann, Nicole R. Davis, Fergus Shanahan, Ronald J. Doll and Emma Lees. Their work appears in journals such as Blood, Cancer Research and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact